Related Experiment Video
Updated: Jul 21, 2026

Surgical Techniques for Catheter Placement and 5/6 Nephrectomy in Murine Models of Peritoneal Dialysis
Published on: July 19, 2018
Peritonitis during continuous ambulatory peritoneal dialysis
Abstract:
We initiated a therapeutic program of continuous ambulatory peritoneal dialysis for patients with chronic renal failure. Our program resulted in many episodes of peritonitis arising from contamination due to the technical aspects of the procedure. Microbiologic evaluation showed that 73% of 97 episodes were culture positive, with gram-positive organisms causing most of the cases, especially early in dialysis. Gram-negative rods tended to occur later. Gram stains of dialysate effluent resulted in a disappointingly low yield of only 9% positivity. Cell counts were a dependable indicator of the presence of peritoneal inflammation and also of therapeutic success. Most patients responded well to intraperitoneal cephalothin, 125 mg/L for 10 to 14 d. The occurrence of peritonitis resulted in 0.93 years of hospitalization during the total of 15.45 patient-years on dialysis, which essentially negated the financial advantages of this method of treatment of chronic renal failure. For this to be a successful mode of therapy, advances in the prevention of peritonitis must be made.
Insights
Continuous ambulatory peritoneal dialysis for chronic renal failure led to frequent peritonitis, increasing hospitalizations and negating cost benefits. Preventing peritonitis is crucial for this therapy to succeed.
Area of Science:
- Nephrology
- Infectious Diseases
- Medical Procedures
Background:
- Continuous ambulatory peritoneal dialysis (CAPD) is a treatment for chronic renal failure.
- Technical aspects of CAPD can lead to peritonitis, a serious complication.
- Effective prevention strategies for peritonitis are needed to ensure CAPD's viability.
Purpose of the Study:
- To evaluate the incidence and microbiology of peritonitis in a CAPD program.
- To assess the effectiveness of intraperitoneal cephalothin in treating peritonitis.
- To determine the impact of peritonitis on hospitalization and the overall success of CAPD.
Main Methods:
- A therapeutic program of CAPD was initiated for patients with chronic renal failure.
- Microbiologic evaluation of 97 peritonitis episodes was performed.
- Dialysate cell counts and gram stains were utilized for diagnosis.
- Treatment efficacy was assessed using intraperitoneal cephalothin.
Main Results:
- 73% of peritonitis episodes were culture-positive, predominantly by gram-positive organisms early on and gram-negative rods later.
- Dialysate gram stains had a low positivity rate (9%).
- Dialysate cell counts reliably indicated peritoneal inflammation and treatment response.
- Peritonitis led to significant hospitalization, offsetting financial benefits of CAPD.
Conclusions:
- Peritonitis is a major challenge in CAPD, significantly impacting patient outcomes and treatment economics.
- While cephalothin showed efficacy, peritonitis prevention remains paramount for successful CAPD therapy.
- Further advancements in CAPD techniques are necessary to minimize peritonitis incidence.
Related Concept Videos
Extracorporeal Removal of Drugs: Peritoneal Dialysis and Hemodialysis
Peritoneal Dialysis I: Introduction and Procedure
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Peritoneal Dialysis III: Nursing Management
Continuous Renal Replacement Therapy
Acute Kidney Injury V: Interprofessional Care

